Increased Use of Prophylactic Measures in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.

ABSTRACT:

Background

Nonsteroidal anti-inflammatory drugs (NSAIDs), pancreatic duct stenting, and intensive intravenous hydration have been proven to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Trial participation and guideline changes demanded an assessment of the clinical practice of post-ERCP pancreatitis prophylaxis.

Aims

The surveys aim to identify points of improvement to inform and educate ERCPists about current evidence-based practice.

Methods

Two anonymous surveys were conducted among Dutch gastroenterologists in 2013 (n = 408) and 2020 (n = 575) for longitudinal views and attitudes pertaining to post-ERCP pancreatitis prophylaxis and recognition of post-ERCP pancreatitis risk factors.

Results

In 2013 and 2020, respectively,

SUBMITTER: Sperna Weiland CJ 

PROVIDER: S-EPMC8589790 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature